ADVERTISEMENT
News
NovoSorb BTM - PolyNovo
04/23/2024
A 42-patient CT will investigate a novel dermal substitute, NovoSorb BTM, for the treatment of full-thickness skin defects versus SoC with primary outcome of skin elasticity at 1 year post-transplantation vs normal skin. Recruitment is ongoing with estimated study completion in June 2027. clinicaltrials.gov